GSK plc GLAXF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.08B | 583.95M | 2.34B | 845.86M | 2.71B |
| Total Depreciation and Amortization | 996.52M | 299.36M | 623.79M | -832.56M | 844.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | 292.59M | -- |
| Total Other Non-Cash Items | -56.48M | 1.98B | 30.99M | 2.18B | 98.43M |
| Change in Net Operating Assets | 762.52M | 751.75M | -1.46B | 541.30M | -660.72M |
| Cash from Operations | 3.78B | 3.61B | 1.54B | 3.03B | 3.00B |
| Capital Expenditure | -502.97M | -440.31M | -297.75M | -762.07M | -419.35M |
| Sale of Property, Plant, and Equipment | 4.03M | 4.03M | 36.38M | 17.29M | 6.74M |
| Cash Acquisitions | -9.75B | -916.87M | -1.90B | -57.19M | -1.16B |
| Divestitures | -17.48M | 20.14M | 330.08M | 1.33M | 1.35M |
| Other Investing Activities | -96.83M | 273.85M | -146.85M | -440.22M | -493.52M |
| Cash from Investing | -10.37B | -1.06B | -1.98B | -1.24B | -2.06B |
| Total Debt Issued | 6.32B | 273.00M | 1.20B | 552.00M | -80.00M |
| Total Debt Repaid | -939.00M | -958.00M | -73.00M | -79.00M | -62.00M |
| Issuance of Common Stock | 0.00 | 1.00M | 8.00M | 1.00M | 0.00 |
| Repurchase of Common Stock | 0.00 | -308.00M | -326.00M | -252.00M | -317.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -917.17M | -975.94M | -866.30M | -859.16M | -876.46M |
| Other Financing Activities | -24.00M | -430.00M | 104.00M | -432.00M | -206.00M |
| Cash from Financing | 6.28B | -2.88B | 366.46M | -1.14B | -1.77B |
| Foreign Exchange rate Adjustments | -45.72M | -9.40M | 2.69M | -54.53M | 79.56M |
| Miscellaneous Cash Flow Adjustments | 0.00 | 57.72M | -- | -- | -- |
| Net Change in Cash | -353.69M | -284.59M | -68.71M | 595.82M | -761.85M |